Tirzepatide
STUDY00004995
Approved small_molecule active
Quick answer
Tirzepatide for Prader-Willi Syndrome is a Approved program (small_molecule) at Grace Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Grace Therapeutics
- Indication
- Prader-Willi Syndrome
- Phase
- Approved
- Modality
- small_molecule
- Status
- active